Physician profile
Ipek Alpertunga
NPI 1386166452
$1,401.73
in general payments reported to CMS, 2019-2025
14 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.66 · 2023: $330 · 2024: $302 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,302.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $231.46 | 2023-2025 | Evenity, Prolia, Prolia |
| Dexcom, INC. | $228.75 | 2023-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $226.12 | 2022-2025 | Ozempic |
| Abbott Laboratories | $178.78 | 2023-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $108.44 | 2024-2025 | Gvoke Hypopen, Recorlev |
| Lilly USA, LLC | $97.64 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Acella Pharmaceuticals, LLC | $66.59 | 2023 | NP Thyroid 60 |
| Beta Bionics, INC. | $66.58 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Tandem Diabetes Care, INC. | $61.92 | 2022-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $42.33 | 2022-2025 | Omnipod |
| Mannkind Corporation | $30.35 | 2025 | |
| Medtronic, INC. | $29.42 | 2023 | Minimed 780g |
| Lifescan, INC. | $17.60 | 2022 | |
| Sequel Med Tech, LLC | $15.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ipek Alpertunga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.